US 6800759
Racemization and enantiomer separation of clopidogrel
expired A61KA61K31/4743
Quick answer
US patent 6800759 (Racemization and enantiomer separation of clopidogrel) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Sep 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Oct 05 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/4743